Efficacy and Safety of Pioglitazone versus Glimepiride after Metformin and Alogliptin Combination Therapy: A Randomized, Open-Label, Multicenter, Parallel-Controlled Study

BACKGROUND: There is limited information regarding the optimal third-line therapy for managing type 2 diabetes mellitus (T2DM) that is inadequately controlled using dual combination therapy. This study assessed the efficacy and safety of pioglitazone or glimepiride when added to metformin plus alogl...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Diabetes Metab J
Главные авторы: Kim, Jeong Mi, Kim, Sang Soo, Kim, Jong Ho, Kim, Mi Kyung, Kim, Tae Nyun, Lee, Soon Hee, Lee, Chang Won, Park, Ja Young, Kim, Eun Sook, Lee, Kwang Jae, Choi, Young Sik, Kim, Duk Kyu, Kim, In Joo
Формат: Artigo
Язык:Inglês
Опубликовано: Korean Diabetes Association 2020
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7043969/
https://ncbi.nlm.nih.gov/pubmed/31339011
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4093/dmj.2018.0274
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы